Page last updated: 2024-10-31

nabumetone and Hyperkalemia

nabumetone has been researched along with Hyperkalemia in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pal, B1
Hutchinson, A1
Bhattacharya, A1
Ralston, A1

Other Studies

1 other study available for nabumetone and Hyperkalemia

ArticleYear
Cardiac arrest due to severe hyperkalaemia in patient taking nabumetone and low salt diet.
    BMJ (Clinical research ed.), 1995, Dec-02, Volume: 311, Issue:7018

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Diet, Sodium-Restricted; Heart Arrest; Hum

1995